Exa Biosciences, Inc. — Form D

Exa Biosciences, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-14. The offering totals $400K, of which $50K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-08-14
• Form: D
• Accession: 0002033324-24-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $400K
• Amount sold: $50K
• Remaining: $350K
• Minimum investment: $10K
• Investors: 1
• Date of first sale: 2024-07-31
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-521473

Issuer

• Name: Exa Biosciences, Inc.
• CIK: 0002033324
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 867 BOYLSTON STREET 5TH FLOOR 1827, BOSTON, MA, 02116
• Phone: 617-458-7968

Officers, directors & promoters (1)

More

• CIK 2033324 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search